« Return to News | Study Conduct

Four more earn AAHRPP accreditation

Friday, June 15, 2012 01:54 PM

The Association for the Accreditation of Human Research Protection Programs has accredited four more organizations: the Children’s Hospital Los Angeles in Los Angeles, Calif.; Ochsner Clinic Foundation in New Orleans, La.; Opus IRB in Roswell, Ga.; and Rush University Medical Center in Chicago, Ill.

Ten years after issuing its first accreditation standards, AAHRPP has accredited more than 50% of U.S. research-intensive universities and U.S. medical schools. In addition, all major U.S. independent review boards are now AAHRPP accredited.

“Over the past 10 years, AAHRPP accreditation has become the gold standard for research protections — the mark of quality for human research protection programs nationwide,” said Marjorie A. Speers, Ph.D., president and CEO of AAHRPP. “As a result, we’ve seen significant improvements in U.S. research protections. Our goal, now, is to achieve similar results worldwide, especially given the increasingly global nature of the research enterprise.”

AAHRPP accreditation is available to U.S. and international organizations that conduct biomedical, behavioral or social sciences research involving human participants.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.